Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tessa Jowell BRAIN MATRIX - Platform Study
Sponsor: University of Birmingham
Summary
The main aim of the Tessa Jowell BRAIN MATRIX - Platform Study is to more precisely determine the exact type of tumour patients have by developing the essential infrastructure to provide rapid and accurate molecular diagnosis. A large network of clinical hubs across the United Kingdom, with expertise in managing patients with brain tumours, will be developed. Once established this infrastructure will facilitate the rapid introduction of clinical trials testing targeted therapies tailored to the genetic changes of an individual's tumour.
Official title: A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2020-11-24
Completion Date
2027-03-01
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Matched Tumour and Blood Sample - Research Pathway
For patient's undergoing surgery fresh tissue will be collected from the initial surgery and frozen until shipment to the Oxford BRAIN MATRIX Lab. Matched blood sample for germline DNA will be taken post-Platform Study entry. For patients with progression with available tumour samples from previous tumour surgery, blood will be collected and sent to Oxford along with their tumour samples. Samples will be shipped together to Oxford for molecular analysis (Whole Genome Sequencing (WGS) and EPIC array). The BRAIN MATRIX neuropathology and genomics team will produce an integrated report (histology, WGS, Heidelberg Classifier) for each case in consultation with the local neuropathology team. Once data is available, a virtual MDT with the BRAIN MATRIX neuropathology, genomics team and local site will be held to ensure all relevant information is incorporated in the final BRAIN MATRIX diagnostic report. The resulting integrated histological-molecular report will be available to local sites
Matched Tumour and Blood Sample - NHS GMS pathway
Tessa Jowell BRAIN MATRIX centres in England can submit matched tissue and blood samples for Whole Genome Sequencing through the standard of care NHS Genomic Medicine Service pathway via their Genomic Laboratory Hub. For those from Devolved Nations, samples must go to the Oxford BRAIN MATRIX Laboratory who can facilitate the processing of samples through an alternative NHS GMS GLH or via the research pathway.
Locations (14)
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Velindre Cancer Centre, Velindre University NHS Trust
Cardiff, United Kingdom
NHS Lothian
Edinburgh, United Kingdom
Queen Elizabeth Unviersity Hospital, NHS Greater Glasgow and Clyde Health Board
Glasgow, United Kingdom
St James's University Hospital, Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
The Walton Centre, The Walton Centre NHS Foundation Trust
Liverpool, United Kingdom
King's College Hospital, King's College Hospital NHS Foundation Trust
London, United Kingdom
Charing Cross Hospital, Imperial College Healthcare NHS Trust
London, United Kingdom
The Christie Hospital, The Christie NHS Foundation Trust
Manchester, United Kingdom
Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust
Manchester, United Kingdom
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom
Queen's Medical Centre, Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom